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Abstract
Patient subtyping based on temporal observations can lead to significantly nuanced
subtyping that acknowledges the dynamic characteristics of diseases. Existing
methods for subtyping trajectories treat the evolution of clinical observations as
a homogeneous process or employ data available at regular intervals. In reality,
diseases may have transient underlying states and a state-dependent observation
pattern. In our paper, we present an approach to subtype irregular patient data
while acknowledging the underlying progression of disease states. Our approach
consists of two components: a probabilistic model to determine the likelihood
of a patient’s observation trajectory and a mixture model to measure similarity
between asynchronous patient trajectories. We demonstrate our model by discover-
ing subtypes of progression to hemodynamic instability (requiring cardiovascular
intervention) in a patient cohort from a multi-institution ICU dataset. We find three
primary patterns: two of which show classic signs of decompensation (rising heart
rate with dropping blood pressure), with one of these showing a faster course of
decompensation than the other. The third pattern has transient period of low heart
rate and blood pressure. We also show that our model results in a 13% reduction in
average cross-entropy error compared to a model with no state progression when
forecasting vital signs.
1 Introduction
Patient subtyping is an important topic in medical informatics. Subtyping can be used to make
improved predictions, understand disease etiologies and healthcare practices, plan customized treat-
ments, and design efficient clinical trials [8, 2, 5, 7]. The medical community has begun to recognize
that many diseases have heterogeneous underlying mechanisms and phenotypes [6, 13]. With increas-
ing amounts of patient data being collected in electronic medical records and large medical databases,
there is a great opportunity to mine data and identify patient subtypes to better patient care and
improve outcomes. Patient subtyping can also have a direct economic impact on the healthcare system
by characterizing current patient-provider interactions and suggesting optimal resource management.
Today’s medical databases have patients’ longitudinal trajectories of observations and interventions
charted along with their time stamps. Subtyping patients based on their temporal observation trajecto-
ries could lead to significantly nuanced subtyping that acknowledges the dynamic characteristics of
diseases. Traditionally, though, patient subtyping has been based either on aggregates of patient’s
entire time course of observations or summaries over blocks of fixed time intervals. These approaches
result in vectors of fixed size for all patients, which are then amenable to well-known clustering
approaches such as K-means clustering, hierarchichal clustering etc [14, 8, 3]. Native data in medical
records, however, are almost always incomplete and irregularly observed over varying time intervals.
The missingness of data is typically tackled by imputation to produce a complete dataset of constant
dimension. Although practically useful, clustering with summary-based fixed dimensional dataset
ignores the rich information in the temporal patterns of clinical observations/interventions. Methods
that subtype raw observation trajectories are being developed in recent times [4, 12, 11]. Existing
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Figure 1: Continuous time HMM describing patients’ disease and observation progression
methods, however, either treat the evolution of clinical markers as a homogeneous process or employ
data available at regular intervals; in reality diseases may have transient underlying states and a state-
dependent observation pattern. In this paper, we present an approach to subtype raw unsummarized
data from electronic medical records, while acknowledging the underlying progression of disease
states. Our approach consists of two components: a probabilistic model to determine the likelihood of
a patient’s observation trajectory and a mixture model to measure similarity between asynchronous
patient trajectories.
2 Methodology
Consider that we have data from N patients, each associated with their time course of observations
given by Yn ≡ {Yn,t1 , Yn,t2 , ..., Yn,tn}. Here, Yn,ti is the vector of observations at time ti and Yn
is the trajectory of observation vectors of patient n. The length of each Yn,ti is D, where D is the
number of features that could be observed. For example, if we have the heart rate, blood pressure,
and respiratory rate measurements of patients, D would be three. Usually, only a subset of the D
features are actually observed at any time, with the specific features observed being different at each
time point. This results in an incomplete observation set with many feature observations missing.
As such, patient observations are made when appropriate—when the patient appears for a routine
check-up or when clinicians ask for specific tests/measurements. As a result, the trajectories of patient
observations do not synchronize in time or the type of features that are observed.
2.1 Patient disease trajectory model
Disease evolution is fundamentally a continuous process: patient’s disease state transitions can
happen at any time with the chance of state transition between any two time points higher if the
time interval is longer. We thus use a continuous-time Markov chain to model the evolution of a
patient’s disease state (See Appendix for details). The disease state of patient n at time ti is denoted
as Zn,ti and takes one of a set of discrete values. The disease state is naturally hidden, i.e., we never
get to observe the actual disease state. In fact, the precise definition of the disease states is apriori
unknown. The disease states can be learnt from data in an unsupervised manner and subsequently the
states interpreted based on the parameters that describe the states. The observation vectors Yn,ti are
surrogates of the underlying disease state Zn,ti . To reflect this behaviour in our model, we model the
observations by a conditionally independent probability model P (Yn,ti |Zn,ti), where observation
Yn,ti is independent of all other observations Yn,tj given the current disease state Zn,ti . Overall, our
model for the patient’s observation trajectory can be described by the continuous-time hidden Markov
model (CT-HMM) shown in Figure 1. The probability of the trajectory of patient n is given by
P (Zn,t1:tn , Yn,t1:tn) = P (Yn,t1:tn |Zn,t1:tn)P (Zn,t1:tn) (2.1)
We use the notation l:r to denote all values ranging from l to r (inclusive of both boundaries). A
common modeling choice that we incorporate in our model is that the features are conditionally
independent given the corresponding disease state, i.e.,
P (Yn,ti |Zn,ti) =
D∏
d=1
P (Yn,ti,d|Zn,ti) (2.2)
The choice of the conditional distribution of the observation Yn,ti,d given the disease state Zn,ti can
be made as per context. Specifically, if we assume that a feature d can fall into one of J bins, the
conditional probability of the jth bin is given by
P (Yn,ti,d = j|Zn,ti = k) = wk,d,j , (2.3)
2
where k refers to the disease state at time ti and wk,d,1:J are the parameters of the categorical
distribution of feature d given disease state k. By construction
∑
j wk,d,j = 1. In case of missing
feature observation, we marginalize that observation from the model. The disease states in a patient’s
observation timeline are unknown. Thus, we can quantify the patient’s observation trajectory by
marginalizing the disease state out of Equation 2.1, giving
P (Yn,t1:tn) =
∑
Zn,t1:tn
P (Zn,t1:tn , Yn,t1:tn). (2.4)
This is we refer to as the likelihood under the patient’s disease trajectory model. Equipped with a
likelihood model of the patient’s observation trajectory, we are now in a position to describe a measure
of similarity between trajectories of different patients. Patients whose observation trajectories are
more probable under a disease trajectory model than other trajectory models can be considered to be
similar trajectories.
2.2 Mixture model
We subtype patients into different clusters using the mixture model. Consider that we are interested in
identifying M subtypes among the patients. The joint distribution of patient n’s subtype assignment
mn and his/her trajectory Yn,t1:tn is given by
P (mn, Yn,t1:tn) = P (mn)P (Yn,t1:tn |mn). (2.5)
Here mn ∈ {1, 2, ...,M} and P (Yn,t1:tn |mn) is evaluated using the disease trajectory model corre-
sponding to subtype mn. To infer the subtypes, we identify patient subtype assignments and subtype
parameters so as to maximize the joint probability of the subtype assignment and the conditional ob-
servation trajectory probability over all patients. Mathematically, assuming independence of patients,
the objective used to identify the subtypes is
{m∗1:N , pi∗1:M , Q∗1:M , w∗1:M} = argmax
m1:N ,pi1:M ,Q1:M ,w1:M
N∏
n=1
P (mn, Yn,t1:tn), (2.6)
where pi1:M , Q1:M , w1:M are subtype-specific parameters. With the above objective, each patient
gets assigned the subtype with the highest posterior probability. Once the optimal parameters are
learnt from the training data, for a new patient not in the training data, the subtype is identified as the
subtype with the highest posterior probability for that patient. Complete details of steps involved in
subtype learning are in the Appendix.
3 Results
3.1 Data summary
We applied our subtyping model to a cohort of 6972 hemodynamically unstable patients obtained from
the eResearch Institute [9]. For our subtyping analyses, we only consider heart rate and noninvasive
systolic blood pressure (nSBP) measurements among various observations made for the patients.
Interventions were given after all heart rate and blood pressure observations. The allowed range of
heart rate values we consider is 40–150 beats/min and that of systolic blood pressure is 40–200 mmHg.
All outliers are treated as missing observations. The observations for both features are discretized
into five equal-sized bins. We tried a few different bin sizes and found the results to be similar.
3.2 Inferring subtypes of hemodynamically unstable patients
We use our subtyping algorithm to identify 4 clusters using the time course of heart rate and blood
pressure measurements and also the intervention time. Thus, effectively, we have three features in the
analysis: heart rate, systolic blood pressure, and an indicator of treatment administration. We force
the administration of an intervention to be the indicator of the final disease state in our model. As a
result, all prior disease states can be viewed relative to the final intervention state. We set the number
of allowed disease states to be 4 and impose a uniform prior distribution on the subtype of all patients.
We allow the initial probability vector to be nonzero for all four disease states. Further, for the present
analysis, we only allow state transitions to the next state, although this assumption can be relaxed in
general. The progression of disease trajectories assuming the patients arrive in state 1 of the inferred
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Figure 2: Progression trajectory of patients starting in disease state 1 for the four subtypes
subtypes are shown in Figure 2. To compute the progression trajectory, we calculate the expected
duration of the four disease states and compute the expected values of the features in each disease
state. We find three primary patterns: subtype 2, 3, and 4 show classic signs of decompensation (rising
heart rate with dropping blood pressure), with subtype 4 showing a faster course of decompensation
than the other two. Subtype 1 has transient period of low heart rate and blood pressure. In general,
across all subtypes we also observe that state 3 has the shortest duration among all disease states.
This corroborates a common observation of quick deterioration—a period of acute changes over a
short time—before intervention among ICU patients.
3.3 Model evaluation by prediction
We evaluate our subtyping algorithm through quantitative tests of prediction on future observations.
For this we split the above cohort into training and test sets in a 80:20 proportion. We only consider
the vital signs (heart rate and blood pressure values) for this analysis and do not include the indicators
of intervention. The evaluation of prediction accuracy is performed as follows. First we use the
training data to learn the subtypes. Once again a uniform prior distribution is imposed on the subtype
of each patient. Having learnt the underlying subtype parameters, for each patient in the test data,
we use the first 70% of the timepoints when observations are made to identify the patient’s subtype.
Knowing the patient’s subtype, we predict the observations at the remaining 30% of the timepoints.
We compare the predicted heart rate and blood pressure bin probabilities with the available data points
to compute the average cross-entropy error over the latter 30% observations. The total forecasting
error is obtained by computing the mean of the cross-entropy error over all patients in the test set.
The estimates of forecasting error and their standard errors with different number of subtypes and
disease states are given in Table 1. We see that there is a consistent reduction in the error with the
Subtypes Disease states
1 2 3 4 5 6
1 1.39± 0.015 1.09± 0.016 1.01± 0.017 0.91± 0.018 0.90± 0.017 0.89± 0.019
2 1.11± 0.018 0.96± 0.018 0.87± 0.018 0.87± 0.019 0.84± 0.019 0.84± 0.019
3 1.00± 0.018 0.90± 0.018 0.84± 0.018 0.83± 0.019 0.79± 0.019 0.81± 0.018
4 0.92± 0.018 0.87± 0.018 0.82± 0.018 0.80± 0.019 0.81± 0.019 0.82± 0.02
5 0.89± 0.017 0.84± 0.018 0.82± 0.019 0.81± 0.019 − −
6 0.88± 0.019 0.85± 0.02 − − − −
Table 1: Forecasting cross-entropy error with different number of subtypes and disease states
increase in disease states for all subtype numbers. In particular, there is a 13% reduction in forecasting
error in predicting patient trajectories with optimal number of subtypes with multiple disease states
as compared to optimal subtyping model with only one disease state. These results demonstrate
the potential of improved subtyping and more accurate forecasting by subtyping patient disease
trajectories while acknowledging the underlying disease progression. A natural direction of future
work would be to learn subtypes of observation trajectories with a richer class of state-conditioned
observation models, e.g., models with polynomial basis.
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4 Appendix
4.1 Continuous time Markov chains
As mentioned in the main text, we model the evolution of disease state P (Zn,ti |Zn,ti−1) with a
continuous-time Markov chain. A continuous-time Markov chain is a continuous-time process on
a state-space (here the different disease states) satisfying the Markov property. This means that if
FZ(s) is all the information about the history of the disease state Z up to time s and s ≤ t, then Z(t)
is independent of all Z(t′), where t′ < s, given Z(s). Mathematically, this can be expressed as
P (Z(t) = k|FZ(s)) = P (Z(t) = k|Z(s)). (4.1)
Further, we assume the process to be time-homogeneous, so that
P (Z(t) = k|Z(s)) = P (Z(t− s) = k|Z(0)). (4.2)
Equations 4.1 and 4.2 define a time-homogeneous continuous-time Markov chain and model the
disease state evolution in our model. We allow K different disease states in our model. The transition
probability of moving from state a to state b over time ∆ in a continuous-time Markov chain is given
by
P (Zn,ti = b|Zn,ti−1 = a, ti − ti−1 = ∆;Q)
= expm(∆Q)ab, (4.3)
where Q is the generator matrix of the Markov process and expm is the matrix exponential. The
probability of the initial state P (Zn,t1) is parameterized by pi = {pi1, pi2, ..., piK} and given by
pik , P (Zn,t1 = k), k = 1, 2, ...,K (4.4)
Algorithm 1 Patient subtyping algorithm
1: Given: Number of subtypes M and observation trajectories {Yn ≡ Yn,t1:tn} of N patients
2: Repeat until convergence:
3: Step 1:
m∗1:n = argmax
m1:n
P (Y1:n,m1:n, p¯i, Q¯, w¯) (4.5)
4: Step 2:
For m=1 to M:
{pi∗m, Q∗m, w∗m} =
argmax
pim,Qm,wm
∏
n∈N(m)
P (Yn,t1:ti ;pim, Qm, wm),
where N(m) are patients assigned to subtype m (4.6)
4.2 Subtype learning
We now present the different steps involved in training the subtyping model. We train our subtyping
model by maximizing the objective (Equation 2.6) using a coordinate ascent optimization algorithm.
The algorithm consists of two alternating steps: Step 1, when each patient trajectory gets assigned to
the subtype with the highest posterior probability, and Step 2, when all patients assigned to a subtype
are used to optimize the parameters of that subtype. The precise mathematical forms of the two steps
are given in Algorithm 1. In Step 2 of the above algorithm, parameters of each subtype are learnt by
training the disease trajectory model described in Section 2.1. The solution of each maximization
problem in Step 2 is a maximum likelihood estimate of the subtype parameters with the data assigned
to that subtype. As was explained in Section 2.1, the likelihood of a patient trajectory P (Yn,t1:tn)
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Algorithm 2 Disease trajectory learning
1: Given: TrajectoriesY ≡ {Yn∈N(m)} of patients assigned to subtype m
2: Zn ≡ Zn,t1:tn and Z ≡ {Zn∈N(m)}
3: Repeat until convergence
4: E-Step:
EP (Z,Z(t)|Y;pi′,Q′,w′) logP (Y,Z,Z(t);pi,Q,w)
= EP (Z,Z(t)|Y;pi′,Q′,w′) logP (Z,Z(t);Q)
+ EP (Z|Y;pi′,Q′,w′) logP (Y|Z;w) (4.7)
5: M-Step:
pim, Qm, wm =
argmax
pi,Q,w
EP (Z,Z(t)|Y) logP (Y,Z,Z(t);pi,Q,w) (4.8)
can be realized by marginalizing the hidden disease states from the joint probability distribution of
the observations and the disease states (Equation 2.4). Thus, the optimization in Step 2 can be solved
with the expectation maximization algorithm. The E- and M- steps in optimizing equation 4.6 are
given in Algorithm 2.
The E-Step and M-Step in Algorithm 2 can be simplified for our construction of the patient disease
trajectory model. The expectation of the first term of the RHS in Equation 4.7 is given by
EP (Z,Z(t)|Y;pi′,Q′,w′) logP (Z,Z(t);pi,Q)
=
∑
∆
∑
a,b∈K
Cab(∆)(
∑
c,d∈[K]
(logQcd)E[Ncd(∆)|Z;Q′]
−QcdE[Rc(∆)|Z;Q′])+
EP (Z|Y;pi′,Q′,w′) logP (Zt1 ;pi), (4.9)
where
Cab(∆) ,∑
n
tn∑
t2
P (Zn,ti−1 = a, Zn,ti = b|Y;pi′, Q′)1ti−ti−1=∆, (4.10)
Nab(∆) is the number of transitions between states a and b in time ∆ andRa(∆) is the duration of
time spent in state a during time interval ∆. A detailed derivation of the above expression can be
found in [10]. The second term of the RHS in Equation 4.7 can be written as
EP (Z,|Y;pi′,Q′,w′) logP (Y|Z)
=
∑
n
tn∑
t=t1
K∑
k=1
D∑
d=1
γn,t,kP (Yn,t,d|Zn,t = k)
=
∑
n
tn∑
t=t1
K∑
k=1
D∑
d=1
γn,t,k
∑
j
w
1Yn,t,d=j
1Yn,t,d
k,d,j , (4.11)
where γn,t,k = P (Zn,t = k|Yn) is the posterior probability of disease state k for patient n at time
point t, 1Yn,t,d is an indicator of feature d not missing at time point t and 1Yn,t,d=j is an indicator
function for observation Yn,t,d belonging to the jth discrete bin.
The M-step in Equation 4.8 results in the following closed-form expressions for the parameters of the
observation model and the initial probability vector:
wk,d,j =
∑
n
∑tn
t=t1
γn,t,k1Yn,t,d1Yn,t,d=j∑
n
∑tn
t=t1
∑
j γn,t,k1Yn,t,d1Yn,t,d=j
(4.12)
pia =
∑
n P (Zn,t1 = a|Yn;pi′, Q′)∑
n
∑K
k=1 P (Zn,t1 = k|Yn;pi′, Q′)
(4.13)
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The generator matrix Q can be updated in each iteration using the closed-form solution:
Qab =
∑
∆
∑
c,d∈[K]
E[Nab(∆)|Z(∆) = d, Z(0) = c;Q′]Cc,d(∆)∑
∆
∑
c,d∈[K]
E[Ra(∆)|Z(∆) = d, Z(0) = c;Q′]Cc,d(∆)
(4.14)
The specific formulae for the involved terms are in [10, 15]. The evaluation of posterior probabilities
γn,t,k and P (Zn,ti−1 = a, Zn,ti = b|Y;pi′, Q′, w′) is done using the forward-backward algorithm
for computing the posterior probabilities in hidden Markov models; detailed derivations are in [1].
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